Engineers Gate Manager LP Cogent Biosciences, Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.06 - $10.08 $46,527 - $115,516	11,460 New	11,460 $67,000
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.24 $34,484 - $46,353	3,501 Added 14.89%	27,019 $319,000
Q1 2023 May 15, 2023	SELL	$10.04 - $15.5 $7,881 - $12,167	-785 Reduced 3.23%	23,518 $253,000
Q4 2022 Feb 14, 2023	BUY	$10.65 - $14.84 $258,826 - $360,656	24,303 New	24,303 $280,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $9.3 $144,857 - $172,273	-18,524 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.47 - $12.34 $138,374 - $228,586	18,524 New	18,524 $163,000

159

114M

104K

163K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $717M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.